Checking for CHEK2 Hereditary Mutations in Ukrainian Women: Lack of CHECK2 Variants Contribution to Breast Cancer Susceptibility

被引：0
|
作者：
Sulaieva, O. [1 ]
Kozakov, D. [1 ]
Livshun, S. [1 ]
Matvieieva, A. [1 ]
Shabalkov, R. [1 ]
机构：
[1] Med Lab CSD, Kiev, Ukraine
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2022年 / 158卷 / SUPP 1期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [21] Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility
    Schutte, M
    Seal, S
    Barfoot, R
    Meijers-Heijboer, H
    Wasielewski, M
    Evans, DG
    Eccles, D
    Meijers, C
    Lohman, F
    Klijn, J
    van den Ouweland, A
    Futreal, PA
    Nathanson, KL
    Weber, BL
    Easton, DF
    Stratton, MR
    Rahman, N
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (04) : 1023 - 1028
  • [22] The risk of breast cancer in women with a CHEK2 mutation
    Cezary Cybulski
    Dominika Wokołorczyk
    Anna Jakubowska
    Tomasz Huzarski
    Tomasz Byrski
    Jacek Gronwald
    Tadeusz Dębniak
    Bohdan Górski
    Steven A Narod
    Jan Lubiński
    Hereditary Cancer in Clinical Practice, 10 (Suppl 1)
  • [23] Association of two mutations in the CHEK2 gene with breast cancer
    Bogdanova, N
    Enssen-Dubrowinskaja, N
    Feshchenko, S
    Lazjuk, GI
    Rogov, YI
    Dammann, O
    Bremer, M
    Karstens, JH
    Sohn, C
    Dörk, T
    INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (02) : 263 - 266
  • [24] CHEK2: the third susceptibility BReast CAncer (BC) gene?
    Gomes, V. L.
    Machado, P.
    Fragoso, S.
    Santos, S.
    Coelho, I.
    Parreira, J.
    Rodrigues, P.
    Rodrigues, F.
    Clara, A.
    Bento, S.
    Luis, A.
    Opiniao, A.
    Vaz, F.
    CANCER RESEARCH, 2019, 79 (04)
  • [25] Survival from breast cancer in patients with CHEK2 mutations
    T. Huzarski
    C. Cybulski
    D. Wokolorczyk
    A. Jakubowska
    T. Byrski
    J. Gronwald
    P. Domagała
    M. Szwiec
    D. Godlewski
    E. Kilar
    E. Marczyk
    M. Siołek
    R. Wiśniowski
    H. Janiszewska
    D. Surdyka
    R. Sibilski
    P. Sun
    J. Lubiński
    S. A. Narod
    Breast Cancer Research and Treatment, 2014, 144 : 397 - 403
  • [26] Survival from breast cancer in patients with CHEK2 mutations
    Huzarski, T.
    Cybulski, C.
    Wokolorczyk, D.
    Jakubowska, A.
    Byrski, T.
    Gronwald, J.
    Domagala, P.
    Szwiec, M.
    Godlewski, D.
    Kilar, E.
    Marczyk, E.
    Siolek, M.
    Wisniowski, R.
    Janiszewska, H.
    Surdyka, D.
    Sibilski, R.
    Sun, P.
    Lubinski, J.
    Narod, S. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 144 (02) : 397 - 403
  • [27] CHEK2 mutations as markers for high risk of breast cancer
    Cezary Cybulski
    Dominika Wokołorczyk
    Anna Jakubowska
    Tomasz Huzarski
    Tomasz Byrski
    Jacek Gronwald
    Tadeusz Dębniak
    Bohdan Górski
    P Blecharz
    S A Narod
    Jan Lubiński
    Hereditary Cancer in Clinical Practice, 10 (Suppl 3)
  • [28] The controversial association of CHEK2 pathogenic variants and colorectal cancer susceptibility
    Freitas, P.
    Melo, M.
    Luis, A.
    Bento, S.
    Fernandes, S.
    Santos, S.
    Fragoso, S.
    Duarte, T.
    Rodrigues, P.
    Vaz, F.
    Miguel, I.
    ANNALS OF ONCOLOGY, 2022, 33 : S342 - S342
  • [29] Germline CHEK2 mutations in Jewish Ashkenazi women at high risk for breast cancer
    Laitman, Yael
    Kaufman, Bella
    Lahad, Ephrat Levy
    Papa, Moshe Z.
    Friedman, Eitan
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2007, 9 (11): : 791 - 796
  • [30] CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours
    N Sodha
    S Bullock
    R Taylor
    G Mitchell
    B Guertl-Lackner
    R D Williams
    S Bevan
    K Bishop
    S McGuire
    R S Houlston
    R A Eeles
    British Journal of Cancer, 2002, 87 : 1445 - 1448
12345